Zweig Advisers’s Eli Lilly LLY Stock Holding History

Zweig Advisers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-45,000	Closed	-$3.77M	–	80
2015 Q3	$3.77M	Hold	45,000	–	–	0.65%	54
2015 Q2	$3.76M	Hold	45,000	–	–	0.57%	54
2015 Q1	$3.27M	Sell	45,000 -10,000	-18%	-$712K	0.47%	62
2014 Q4	$3.79M	Hold	55,000	–	–	0.52%	57
2014 Q3	$3.57M	Sell	55,000 -40,000	-42%	-$2.53M	0.51%	60
2014 Q2	$5.91M	Sell	95,000 -13,000	-12%	-$776K	0.82%	60
2014 Q1	$6.36M	Hold	108,000	–	–	0.9%	55
2013 Q4	$5.51M	Hold	108,000	–	–	0.76%	69
2013 Q3	$5.44M	Sell	108,000 -23,000	-18%	-$1.2M	0.81%	63
2013 Q2	$6.43M	Buy	+131,000	New	+$7.13M	0.99%	66

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Zweig Advisers's LLY Position: Q4 2015 in Review

Zweig Advisers sold out of Eli Lilly (LLY) in Q4 2015, closing a stake of 45,000 shares — an estimated $3.77M sold.

Zweig Advisers first reported a position in LLY in Q2 2013 and held it in 10 quarters. The position peaked at $6.43M in Q2 2013. 1,220 funds tracked by Wall St. Rank hold LLY as of Q4 2015.

Zweig Advisers reported no remaining Eli Lilly position as of Q4 2015 after selling out during the quarter.
Zweig Advisers sold 45,000 Eli Lilly shares in Q4 2015, an estimated $3.77M.
Zweig Advisers first reported a position in Eli Lilly in Q2 2013 and held it in 10 quarters.
Zweig Advisers's Eli Lilly position peaked at $6.43M in Q2 2013.
1,220 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2015.

Based on Zweig Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.